Stoneridge appoints Aron R. English to board under cooperation agreement with 22NW

STONERIDGE INC

22NW owns ~8.2% of SRI shares; cooperation agreement signed Feb 26, 2026.
Board increased from 7 to 8; English appointed effective March 16, 2026, will be nominated at 2026 annual meeting.
Standstill: 22NW cannot exceed 12.9% ownership, no proxy solicitation, no short sales.
Voting commitments: 22NW must vote for board nominees and against shareholder proposals unless ISS/Glass Lewis disagree.
English is founder of 22NW, CFA charterholder, also on Anebulo Pharmaceuticals board.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

STONERIDGE INC entered into Cooperation Agreement with 22NW Fund, LP, 22NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., and Aron R. English (effective 2026-02-26).

Action: entry
Counterparty: 22NW Fund, LP, 22NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., and Aron R. English
Effective: 2026-02-26

Exact text from the filing

On February 26, 2026, Stoneridge, Inc., an Ohio corporation (the “Company”), entered into a Cooperation Agreement (the “Cooperation Agreement”) with 22NW Fund, LP, a Delaware limited partnership, 22NW, LP, a Delaware limited partnership, 22NW Fund GP, LLC, a Delaware limited liability company, 22NW GP, Inc., a Delaware S corporation, and Aron R. English (collectively, “22NW” or the “Investor Group”).

View on SEC.gov

317 material agreements filed in the last 30 days. Browse all material agreements →

STONERIDGE INC filing history →

Source: SEC EDGAR

accession 0001043337-26-000014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.